U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Metastatic Paranasal Sinus Squamous Cell Carcinoma

MedGen UID:
1698969
•Concept ID:
C5206854
•
Neoplastic Process

Definition

Paranasal sinus squamous cell carcinoma that has spread from its original site of growth to another anatomic site. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVMetastatic Paranasal Sinus Squamous Cell Carcinoma

Professional guidelines

PubMed

Management of orbital invasion in sinonasal squamous cell carcinoma: 15 years' experience.
Li R, Tian S, Zhu Y, Zhu W, Wang S
Int Forum Allergy Rhinol 2020 Feb;10(2):243-255. Epub 2019 Nov 22 doi: 10.1002/alr.22465. PMID: 31756058
The Role of Targeted Therapy in the Management of Sinonasal Malignancies.
Kashat L, Le CH, Chiu AG
Otolaryngol Clin North Am 2017 Apr;50(2):443-455. doi: 10.1016/j.otc.2016.12.016. PMID: 28314406
Management of the neck in maxillary sinus carcinomas.
Dooley L, Shah J
Curr Opin Otolaryngol Head Neck Surg 2015 Apr;23(2):107-14. doi: 10.1097/MOO.0000000000000138. PMID: 25692625Free PMC Article

Recent clinical studies

Etiology

Sinonasal Squamous Cell Carcinoma Survival Outcomes Following Induction Chemotherapy vs Standard of Care Therapy.
Murr AT, Lenze NR, Weiss JM, Grilley-Olson JE, Patel SA, Shen C, Chera BS, Zanation AM, Thorp BD, Sheth SH
Otolaryngol Head Neck Surg 2022 Nov;167(5):846-851. Epub 2022 Mar 8 doi: 10.1177/01945998221083097. PMID: 35259033Free PMC Article
Prognostic Factors of Sinonasal Squamous Cell Carcinomas Arising De Novo and From Inverted Papilloma.
Li Y, Wang C, Wang R, Zhang J, Liu H, Shi Q, Chen X, Hou L, Ma H, Zhong Q, Li P, Feng L, He S, Zhang L, Fang J
Am J Rhinol Allergy 2021 Jan;35(1):114-121. Epub 2020 Jul 12 doi: 10.1177/1945892420939422. PMID: 32659112
PI3K/AKT/mTOR pathway and autophagy regulator genes in paranasal squamous cell carcinoma metastasis.
Biray Avci C, Sezgin B, Goker Bagca B, Karci HB, Gode S
Mol Biol Rep 2020 May;47(5):3641-3651. Epub 2020 Apr 21 doi: 10.1007/s11033-020-05458-8. PMID: 32319010
Squamous cell carcinoma of the maxillary sinus: A population-based analysis.
Dubal PM, Bhojwani A, Patel TD, Zuckerman O, Baredes S, Liu JK, Eloy JA
Laryngoscope 2016 Feb;126(2):399-404. Epub 2015 Sep 22 doi: 10.1002/lary.25601. PMID: 26393540
Management of the neck in maxillary sinus carcinomas.
Dooley L, Shah J
Curr Opin Otolaryngol Head Neck Surg 2015 Apr;23(2):107-14. doi: 10.1097/MOO.0000000000000138. PMID: 25692625Free PMC Article

Diagnosis

5-Aminolevulinic Acid Fluorescence-Guided Surgery in Head and Neck Squamous Cell Carcinoma.
Filip P, Lerner DK, Kominsky E, Schupper A, Liu K, Khan NM, Roof S, Hadjipanayis C, Genden E, Iloreta AMC
Laryngoscope 2024 Feb;134(2):741-748. Epub 2023 Aug 4 doi: 10.1002/lary.30910. PMID: 37540051
Occurrence and Prognosis of Secondary Lung Cancer in Patients with Primary Nasal Cavity and Sinus Squamous Cell Carcinoma.
Feng J, Jin G, Song X
Adv Ther 2022 Jun;39(6):2533-2543. Epub 2022 Mar 31 doi: 10.1007/s12325-022-02107-3. PMID: 35357667
Squamous cell carcinoma of the maxillary sinus: A population-based analysis.
Dubal PM, Bhojwani A, Patel TD, Zuckerman O, Baredes S, Liu JK, Eloy JA
Laryngoscope 2016 Feb;126(2):399-404. Epub 2015 Sep 22 doi: 10.1002/lary.25601. PMID: 26393540
Paranasal sinus squamous cell carcinoma incidence and survival based on Surveillance, Epidemiology, and End Results data, 1973 to 2009.
Ansa B, Goodman M, Ward K, Kono SA, Owonikoko TK, Higgins K, Beitler JJ, Grist W, Wadsworth T, El-Deiry M, Chen AY, Khuri FR, Shin DM, Saba NF
Cancer 2013 Jul 15;119(14):2602-10. Epub 2013 May 14 doi: 10.1002/cncr.28108. PMID: 23674262
Imaging of nasopharyngeal carcinoma.
Goh J, Lim K
Ann Acad Med Singap 2009 Sep;38(9):809-16. PMID: 19816641

Therapy

Sinonasal Squamous Cell Carcinoma Survival Outcomes Following Induction Chemotherapy vs Standard of Care Therapy.
Murr AT, Lenze NR, Weiss JM, Grilley-Olson JE, Patel SA, Shen C, Chera BS, Zanation AM, Thorp BD, Sheth SH
Otolaryngol Head Neck Surg 2022 Nov;167(5):846-851. Epub 2022 Mar 8 doi: 10.1177/01945998221083097. PMID: 35259033Free PMC Article
Cetuximab and paclitaxel combination therapy for recurrent basaloid squamous cell carcinoma in the ethmoid sinus.
Koyama S, Fujiwara K, Morisaki T, Fujii T, Nakamura Y, Fukuhara T, Takeuchi H
Auris Nasus Larynx 2021 Dec;48(6):1189-1192. Epub 2020 Jul 16 doi: 10.1016/j.anl.2020.07.002. PMID: 32684403
Management of orbital invasion in sinonasal squamous cell carcinoma: 15 years' experience.
Li R, Tian S, Zhu Y, Zhu W, Wang S
Int Forum Allergy Rhinol 2020 Feb;10(2):243-255. Epub 2019 Nov 22 doi: 10.1002/alr.22465. PMID: 31756058
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC).
Cohen EEW, Bell RB, Bifulco CB, Burtness B, Gillison ML, Harrington KJ, Le QT, Lee NY, Leidner R, Lewis RL, Licitra L, Mehanna H, Mell LK, Raben A, Sikora AG, Uppaluri R, Whitworth F, Zandberg DP, Ferris RL
J Immunother Cancer 2019 Jul 15;7(1):184. doi: 10.1186/s40425-019-0662-5. PMID: 31307547Free PMC Article
Paranasal sinus squamous cell carcinoma incidence and survival based on Surveillance, Epidemiology, and End Results data, 1973 to 2009.
Ansa B, Goodman M, Ward K, Kono SA, Owonikoko TK, Higgins K, Beitler JJ, Grist W, Wadsworth T, El-Deiry M, Chen AY, Khuri FR, Shin DM, Saba NF
Cancer 2013 Jul 15;119(14):2602-10. Epub 2013 May 14 doi: 10.1002/cncr.28108. PMID: 23674262

Prognosis

Occurrence and Prognosis of Secondary Lung Cancer in Patients with Primary Nasal Cavity and Sinus Squamous Cell Carcinoma.
Feng J, Jin G, Song X
Adv Ther 2022 Jun;39(6):2533-2543. Epub 2022 Mar 31 doi: 10.1007/s12325-022-02107-3. PMID: 35357667
Cetuximab and paclitaxel combination therapy for recurrent basaloid squamous cell carcinoma in the ethmoid sinus.
Koyama S, Fujiwara K, Morisaki T, Fujii T, Nakamura Y, Fukuhara T, Takeuchi H
Auris Nasus Larynx 2021 Dec;48(6):1189-1192. Epub 2020 Jul 16 doi: 10.1016/j.anl.2020.07.002. PMID: 32684403
Prognostic Factors of Sinonasal Squamous Cell Carcinomas Arising De Novo and From Inverted Papilloma.
Li Y, Wang C, Wang R, Zhang J, Liu H, Shi Q, Chen X, Hou L, Ma H, Zhong Q, Li P, Feng L, He S, Zhang L, Fang J
Am J Rhinol Allergy 2021 Jan;35(1):114-121. Epub 2020 Jul 12 doi: 10.1177/1945892420939422. PMID: 32659112
PI3K/AKT/mTOR pathway and autophagy regulator genes in paranasal squamous cell carcinoma metastasis.
Biray Avci C, Sezgin B, Goker Bagca B, Karci HB, Gode S
Mol Biol Rep 2020 May;47(5):3641-3651. Epub 2020 Apr 21 doi: 10.1007/s11033-020-05458-8. PMID: 32319010
Squamous cell carcinoma of the maxillary sinus: A population-based analysis.
Dubal PM, Bhojwani A, Patel TD, Zuckerman O, Baredes S, Liu JK, Eloy JA
Laryngoscope 2016 Feb;126(2):399-404. Epub 2015 Sep 22 doi: 10.1002/lary.25601. PMID: 26393540

Clinical prediction guides

Occurrence and Prognosis of Secondary Lung Cancer in Patients with Primary Nasal Cavity and Sinus Squamous Cell Carcinoma.
Feng J, Jin G, Song X
Adv Ther 2022 Jun;39(6):2533-2543. Epub 2022 Mar 31 doi: 10.1007/s12325-022-02107-3. PMID: 35357667
Sinonasal Squamous Cell Carcinoma Survival Outcomes Following Induction Chemotherapy vs Standard of Care Therapy.
Murr AT, Lenze NR, Weiss JM, Grilley-Olson JE, Patel SA, Shen C, Chera BS, Zanation AM, Thorp BD, Sheth SH
Otolaryngol Head Neck Surg 2022 Nov;167(5):846-851. Epub 2022 Mar 8 doi: 10.1177/01945998221083097. PMID: 35259033Free PMC Article
Cetuximab and paclitaxel combination therapy for recurrent basaloid squamous cell carcinoma in the ethmoid sinus.
Koyama S, Fujiwara K, Morisaki T, Fujii T, Nakamura Y, Fukuhara T, Takeuchi H
Auris Nasus Larynx 2021 Dec;48(6):1189-1192. Epub 2020 Jul 16 doi: 10.1016/j.anl.2020.07.002. PMID: 32684403
Prognostic Factors of Sinonasal Squamous Cell Carcinomas Arising De Novo and From Inverted Papilloma.
Li Y, Wang C, Wang R, Zhang J, Liu H, Shi Q, Chen X, Hou L, Ma H, Zhong Q, Li P, Feng L, He S, Zhang L, Fang J
Am J Rhinol Allergy 2021 Jan;35(1):114-121. Epub 2020 Jul 12 doi: 10.1177/1945892420939422. PMID: 32659112
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC).
Cohen EEW, Bell RB, Bifulco CB, Burtness B, Gillison ML, Harrington KJ, Le QT, Lee NY, Leidner R, Lewis RL, Licitra L, Mehanna H, Mell LK, Raben A, Sikora AG, Uppaluri R, Whitworth F, Zandberg DP, Ferris RL
J Immunother Cancer 2019 Jul 15;7(1):184. doi: 10.1186/s40425-019-0662-5. PMID: 31307547Free PMC Article

Recent systematic reviews

Survival Outcomes of De Novo vs Inverted Papilloma-Associated Sinonasal Squamous Cell Carcinoma: A Systematic Review and Meta-analysis.
Lee JJ, Peterson AM, Embry TW, Wamkpah NS, Kallogjeri D, Doering MM, Schneider JS, Klatt-Cromwell CN, Pipkorn P
JAMA Otolaryngol Head Neck Surg 2021 Apr 1;147(4):350-359. doi: 10.1001/jamaoto.2020.5261. PMID: 33507208Free PMC Article
Endoscopic Resection of Sinonasal Malignancy: A Systematic Review and Meta-analysis.
Rawal RB, Farzal Z, Federspiel JJ, Sreenath SB, Thorp BD, Zanation AM
Otolaryngol Head Neck Surg 2016 Sep;155(3):376-86. Epub 2016 May 10 doi: 10.1177/0194599816646968. PMID: 27165676

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...